Navigation Links
General tumor marker test now offered by GenWay clinical laboratory
Date:8/21/2009

(San Diego, CA) August 21, 2009 GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this testing service. This is an ELISA-based assay which simply requires a small blood sample from the patient in order to quantify the amount of the tumor marker in their serum. This unique and proprietary test formula detects and quantifies specific biomarkers, tumor fibrin and fibrinogen degradation products (tFFDP), which are by-products of cancer cells. Elevated tFFDP levels have been associated with at least 14 different cancer types including lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant lymphoma, brain and pancreatic cancer making it one of the most versatile cancer biomarkers available. GenWay is continuing to evaluate the use of this test in other applications. This general tumor marker test can identify elevated levels of tFFDP in a patient which could potentially correspond to the presence of a malignant tumor.


'/>"/>

Contact: Jill Dombrauckas, Ph.D.
jdom@genwaybio.com
GenWay Biotech
Source:Eurekalert

Page: 1

Related biology news :

1. American Society for Microbiology to host 109th general meeting in Philadelphia
2. Journal of General Physiology explores mysteries of TRP channels in latest Perspectives series
3. Mass. Generals Warren Triennial Prize honors discoverers of microRNAs
4. March of Dimes announces Prematurity Campaign expansion at Surgeon Generals conference
5. Mass. General study shows how exercise changes structure and function of heart
6. American Society for Microbiology 108th General Meeting
7. Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference
8. In nature -- and maybe the corner office -- scientists find that generalists can thrive
9. Generalist bacteria discovered in coastal waters may be more flexible than known before
10. Society for General Microbiology 161st Meeting, University of Edinburgh
11. Tumor suppressor pulls double shift as reprogramming watchdog
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/7/2017)... 2017 Brandwatch , the leading social intelligence company, ... Trust to uncover insights to support its reporting, help direct ... The UK,s leading youth charity will be using Brandwatch Analytics social ... a better understanding of the topics and issues that are a ... ...
(Date:3/2/2017)... LONDON , March 2, 2017 Who ... infringement lawsuits? Download the full report: https://www.reportbuyer.com/product/4313699/ ... ON THE FINGERPRINT SENSOR FIELD? Fingerprint sensors using ... smartphones. The fingerprint sensor vendor Idex forecasts an increase ... in mobile devices and of the fingerprint sensor market ...
(Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... MarketNewsUpdates.com News Commentary  ... The traditional ways to ... as of late due to the rise of the opioid ... dramatic impact on patient,s quality of life as Biotech and ... new forms of opioid formulations that prevent abuse. Biotech and ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, ... their live events series, “Stem Cell Therapy: The Next Phase in the Evolution of ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... unveiled its innovative Quantum peristaltic pump with patented ReNu single-use (SU) cartridge ... new standard for high-pressure feed pumps in SU tangential flow filtration (TFF), ...
(Date:3/22/2017)... 2017  Personal Genome Diagnostics Inc. (PGDx) today ... with the U.S. Department of Veterans Affairs (VA) ... the company,s new CancerSELECT ™ 125 test. ... profiling test that includes microsatellite instability status (MSI), ... to checkpoint inhibitor immunotherapies. CancerSELECT 125 will be ...
Breaking Biology Technology: